PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+20.2%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$4.36B
AUM Growth
+$4.36B
(+23%)
Cap. Flow
+$460M
Cap. Flow
% of AUM
10.56%
Top 10 Holdings %
Top 10 Hldgs %
53.12%
Holding
126
New
23
Increased
23
Reduced
17
Closed
18
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$181M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$179M |
| 3 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$90.3M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$46.7M |
| 5 |
Zymeworks
ZYME
|
$39.5M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$148M |
| 2 |
Ascendis Pharma
ASND
|
$73.7M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$19.5M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$17.3M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$16.4M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Financials | 0.76% |
| 3 | Technology | 0.14% |
| 4 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $340M | 7.8% | 4,023,862 +265,200 | +7% | +$22.4M |
|
|
GBT
2
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $304M | 6.97% | 5,775,726 +250,000 | +5% | +$13.1M |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $299M | 6.85% | 2,899,606 +1,735,224 | +149% | +$179M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $292M | 6.7% | 11,915,127 -320,684 | -3% | -$7.86M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $268M | 6.16% | 21,509,486 -130,000 | -0.6% | -$1.62M |
|
|
ATNX
6
DELISTED
Athenex, Inc. Common Stock
ATNX
| $188M | 4.31% | 9,822,118 +4,726,096 | +93% | +$90.3M |
|
|
7
BridgeBio Pharma
BBIO
$9.89B
| $181M | 4.15% | +6,706,268 | New | +$181M |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $168M | 3.85% | 3,507,223 -362,268 | -9% | -$17.3M |
|
9
MeiraGTx Holdings
MGTX
$587M
| $156M | 3.57% | 6,007,746 | – | – |
|
|
AMRN
10
Amarin Corp
AMRN
$311M
| $120M | 2.76% | 6,201,269 -339,688 | -5% | -$6.59M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $114M | 2.63% | 1,212,731 -58,323 | -5% | -$5.5M |
|
|
QTNT
12
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $101M | 2.31% | 10,789,054 | – | – |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $80.9M | 1.86% | 1,380,171 -20,000 | -1% | -$1.17M |
|
14
Travere Therapeutics
TVTX
$1.56B
| $75.8M | 1.74% | 3,772,582 +717,875 | +24% | +$14.4M |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $73.8M | 1.69% | 1,137,765 +720,816 | +173% | +$46.7M |
|
16
Crinetics Pharmaceuticals
CRNX
$2.92B
| $64.7M | 1.48% | 2,587,953 | – | – |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $55.2M | 1.27% | 1,100,511 +112,000 | +11% | +$5.62M |
|
|
ALBO
18
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $54.9M | 1.26% | 1,704,330 | – | – |
|
|
19
Ascendis Pharma
ASND
$11.8B
| $54.5M | 1.25% | 473,475 -639,853 | -57% | -$73.7M |
|
|
20
Zymeworks
ZYME
$1.12B
| $52.1M | 1.2% | 2,368,890 +1,795,000 | +313% | +$39.5M |
|
|
DOVA
21
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $50.1M | 1.15% | 3,553,060 +427,209 | +14% | +$6.02M |
|
22
Regenxbio
RGNX
$451M
| $49.9M | 1.14% | 970,997 -174,729 | -15% | -$8.98M |
|
23
Merit Medical Systems
MMSI
$5.36B
| $48.7M | 1.12% | 817,209 -235,889 | -22% | -$14M |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $48.1M | 1.1% | 1,038,390 -3,190,510 | -75% | -$148M |
|
|
VRAY
25
DELISTED
ViewRay, Inc.
VRAY
| $48.1M | 1.1% | 5,455,243 +649,593 | +14% | +$5.72M |
|